ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation

Sponsor
University of Bern (Other)
Overall Status
Completed
CT.gov ID
NCT04380909
Collaborator
(none)
107
1
2
14.8
7.3

Study Details

Study Description

Brief Summary

As part of the ROCO project, the University of Bern is investigating an online self-help program for people who are psychologically distressed due to the situation surrounding Covid-19. The ROCO program offers support in overcoming this psychological distress. ROCO stands for a 3-week online self-help program comprising 6 modules.

The aim of the study is to investigate the efficacy of an online self-help intervention for people with psychological distress due to the situation surrounding Covid-19. All participants will be randomized to one of two groups: The first group receives direct access to the online self-help intervention and the second group is a waiting control group that receives access to the program 3 weeks later. In both conditions additional care or treatment is allowed.

There are 4 assessments, which all take place online: baseline, post assessment (after 3 weeks) and two follow-up assessments (after 6 and 18 weeks). All participants from both groups are asked to fill out all assessments.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Internet-based self-help
  • Behavioral: Internet-based self-help after 3 weeks
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
107 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Randomized Controlled Trial (RCT) to Evaluate the Efficacy of an Internet-based Self-help Program for People With Psychological Distress Due to Covid-19
Actual Study Start Date :
May 6, 2020
Actual Primary Completion Date :
Jul 29, 2021
Actual Study Completion Date :
Jul 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Internet-based self-help

The self-help program consists of six text- and video-based modules. All participants in this group receive immediate access to the self-help program. The program's self-management approach does not provide for regular support from a specialist. However, participants can contact the study team if they need or want additional help.

Behavioral: Internet-based self-help
Six cognitive-behavioral, mindfulness and acceptance commitment based modules focusing on different aspects of psychological distress due to the Covid-19 situation.

Other: Waiting control group

Access to internet-based intervention after 3 weeks.

Behavioral: Internet-based self-help after 3 weeks
Six cognitive-behavioral, mindfulness and acceptance commitment based modules focusing on different aspects of psychological distress due to the Covid-19 situation.

Outcome Measures

Primary Outcome Measures

  1. Patient Health Questionnaire (Löwe et al., 2002) [up to 18 weeks]

    9-item questionnaire assessing depressive symptoms

Secondary Outcome Measures

  1. Suicide Behavior Questionnaire Revised (Glaesmer et al., 2018) [up to 18 weeks]

    4-item questionnaire assessing suicidal ideation

  2. DASS-21: Depression, Angst, Stress-Skala (Lovibond & Lovibond, 1995) [up to 18 weeks]

    21-item questionnaire assessing depression, anxiety and stress symptoms

  3. SF-12: Short Form Health Survey (Ware et al., 1996) [up to 18 weeks]

    12-item questionnaire assessing various aspects of well-being

  4. LOT-R: Revised Life Orientation Test (Herzberg et al., 2006) [up to 18 weeks]

    10-item questionnaire assessing optimism and pessimism

  5. Berner Verbitterungsinventar Kurzversion (Znoj, 2008) [up to 18 weeks]

    6-item questionnaire assessing embitterment

  6. Emotion regulation skills SEK-27 (Berking & Znoj, 2008) [up to 18 weeks]

    27-item questionnaire assessing emotion regulation skills

  7. SWE: Skala zur Allgemeinen Selbstwirksamkeit (Jerusalem & Schwarzer, 2003) [up to 18 weeks]

    10-item questionnaire assessing general self-efficacy

  8. UCLA Loneliness Scale (Döring & Bortz, 1993) [up to 18 weeks]

    9-item questionnaire assessing loneliness

  9. Connor-Davidson Resilience Scale (Sarubin et al., 2015) [up to 18 weeks]

    10-item questionnaire assessing resilience

  10. ZUF-8: Zufriedenheitsfragebogen (Attkisson & Zwick, 1982) [at 3 weeks for experimental group and at 6 weeks for waiting control group]

    8-item questionnaire assessing content with an online-program

  11. SUS: System Usability Scale (Brooke, 1996) [at 3 weeks for experimental group and at 6 weeks for waiting control group]

    10-item questionnaire assessing usability of an online-program

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Be at least 18 years old

  • Give a declaration of consent to participate in the study

  • Have access to the internet

  • Understand and master the German language to the degree that they understand the contents and instructions of the study

  • Exceed a cut-off value of 4 points on the Brief Patient Health Questionnaire (PHQ-9; Löwe, Spitzer, Zipfel, & Herzog, 2002)

  • Be able to specify an emergency address in the event of an acute crisis

Exclusion Criteria:
  • Suicidal tendencies (SBQ-R Score ≥ 8)

  • Existence of a known diagnosis of a psychotic or bipolar disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universität Bern Bern Switzerland 3012

Sponsors and Collaborators

  • University of Bern

Investigators

  • Study Director: Hansjörg Znoj, Prof. Dr., University of Bern
  • Principal Investigator: Thomas Berger, Prof. Dr., University of Bern

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Bern
ClinicalTrials.gov Identifier:
NCT04380909
Other Study ID Numbers:
  • 2020-00990
First Posted:
May 8, 2020
Last Update Posted:
Aug 24, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2021